What's new

Human medicines European public assessment report (EPAR): Aqumeldi, Enalapril maleate, Date of authorisation: 15/11/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Aqumeldi, Enalapril maleate, Date of authorisation: 15/11/2023, Revision: 1, Status: Authorised

May 12, 2025 - 13:19
 0
Human medicines European public assessment report (EPAR): Aqumeldi, Enalapril maleate, Date of authorisation: 15/11/2023, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Aqumeldi, Enalapril maleate, Date of authorisation: 15/11/2023, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Grupo Bimbo plans layoffs in Spain

Next Article

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, ...

Related Posts

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

May 8, 2025  0

CVMP Interested Parties’ meeting May 2025, European Medicines Agency, Amsterdam, the Netherlands, from 14 May 2024, 17:00 (CEST) to 14 May 2024, 19:00 (CEST)

CVMP Interested Parties’ meeting May 2025, European Med...

May 5, 2025  0

Human medicines European public assessment report (EPAR): Imatinib Accord, imatinib, Date of authorisation: 30/06/2013, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

May 6, 2025  0